HARROW, INC. — Investor Relations & Filings
Filings indexed
840
across all filing types
Latest filing
2012-02-23
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
HROW
Harrow, Inc. is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic products. The company provides eyecare professionals and their patients with a comprehensive portfolio of innovative, accessible, and affordable solutions designed to enhance patient care and improve vision outcomes. Its offerings include a growing portfolio of branded therapies, essential ophthalmic medications, and specialized compounding services. Harrow focuses on expanding access to high-quality treatments, combining innovation with affordability to redefine eyecare.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| QUARTERLY REPORT | 2012-02-23 | English | |
| QUARTERLY REPORT | 2012-02-23 | English | |
| ANNUAL REPORT | 2012-02-23 | English | |
| DEFINITIVE 14C | 2012-02-06 | English | |
| SCHEDULE 14C INFORMATION | 2012-01-25 | English | |
| FORM 8-K CURRENT REPORT | 2012-01-25 | English |
Browse filings by year
21 years- 2026 10 filings
- 2025 56 filings
- 2024 48 filings
- 2023 41 filings
- 2022 55 filings
- 2021 78 filings
- 2020 48 filings
- 2019 49 filings
- 2018 42 filings
- 2017 54 filings
- 2016 52 filings
- 2015 51 filings
- 2014 40 filings
- 2013 46 filings
- 2012 56 filings
- 2011 11 filings
- 2010 21 filings
- 2009 17 filings
- 2008 42 filings
- 2007 19 filings
- 2006 4 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2012
6 filings
| |||||
| 11971615 | QUARTERLY REPORT | 2012-02-23 | English | ||
| 11971612 | QUARTERLY REPORT | 2012-02-23 | English | ||
| 11971613 | ANNUAL REPORT | 2012-02-23 | English | ||
| 11971616 | DEFINITIVE 14C | 2012-02-06 | English | ||
| 11971617 | SCHEDULE 14C INFORMATION | 2012-01-25 | English | ||
| 11971618 | FORM 8-K CURRENT REPORT | 2012-01-25 | English | ||
|
2011
9 filings
| |||||
| 11971621 | FORM 8-K CURRENT REPORT | 2011-12-20 | English | ||
| 11971622 | FORM 8-K | 2011-09-20 | English | ||
| 11971623 | FORM 8-K | 2011-08-01 | English | ||
| 11971625 | FORM 8-K | 2011-06-27 | English | ||
| 11971627 | FORM 8-K | 2011-05-17 | English | ||
| 11971628 | FORM 8-K | 2011-04-20 | English | ||
| 11971629 | FORM 12B-25 | 2011-03-31 | English | ||
| 11971630 | SCHEDULE 13G AMENDMENT 1 | 2011-02-15 | English | ||
| 11971632 | SCHEDULE 13G/A | 2011-02-10 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
HARROW, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31774/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31774 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31774 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31774 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31774}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HARROW, INC. (id: 31774)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.